For questions about this article or underlying research, email help@trefis.com.
Why HSIC Stock advanced +1.74% Today — RQD Quant Desk Flash
Henry Schein Inc. (HSIC) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Why HSIC Stock advanced +1.74% Today — RQD Quant Desk Flash
Henry Schein Inc. (HSIC) advanced +1.74% to $86.44 as options desks priced 55% call premium vs. 45% put protection around the $85 max-pain magnet. Solid 31% profit margin (11% return on capital), mixed timing at 23x P/E—hold if owned, no rush to chase.
- ▸Technical Tape: Trading at 80% of its 52-week range ($63.04 – $92.18) with RSI-14 at 47.8 (NEUTRAL RANGE).
- ▸Whale Options Positioning: $2.5M in bullish call flow vs. $2.0M in put flow (Put/Call 0.83x, implied earnings swing ±6.5%).
- ▸Fundamental Anchor: Roarable C (Hold) backed by 31.1% gross margin and $118.7M annual free cash flow.
IDEXX Laboratories (NASDAQ:IDXX) is scheduled to report its earnings on Monday, November 2, 2026. The company has a market value of about $45.5 billion. Over the last twelve months it generated $4.6 billion in revenue an
For questions about this article or underlying research, email help@trefis.com.
Henry Schein (HSIC) heads into its upcoming November 3 earnings release with expectations for slightly lower quarterly earnings per share, even as revenue is projected higher, putting the focus firmly on profit resilienc
Staar Surgical (STAA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
American Public Education, Inc. (Nasdaq: APEI), the parent company of American Public University System, has appointed Shira Goodman to its board of directors. Goodman brings extensive executive leadership and corporate
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HSIC gears up for Q3 earnings with revenue growth expected across its three segments, fueled by dental products, specialty demand and cloud-based technology.
MELVILLE, N.Y., October 20, 2026--Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of healthcare solutions to office-based dental and medical practitioners, announced today that it will release its third q
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how dental equipment & technology stocks fared in Q2, starting with Henry Schein (NASDAQ:
Today's Top 3 RQD Strong Buys & Whale Accumulation Setups (Live HSIC Tape Review)
- ✓Live breakdown of today’s highest-scoring RQD Green-Light breakouts
- ✓1 urgent Red-Light accounting trap to cut from your watchlist immediately
- ✓Bring any ticker to live Q&A—we run it through the 5-Pillar RQD Radar on screen
HSIC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +4.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on HSIC today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for HSIC. Explore sector supply chains on /butterfly.
HSIC Investor FAQ & Complete 8-Part Research Index
100% OPEN ACCESS • SEC EDGAR × CBOE × FREDWhy is HSIC stock moving today?
Why HSIC Stock advanced +1.74% Today — RQD Quant Desk Flash. Solid 31% profit margin (11% return on capital), mixed timing at 23x P/E—hold if owned, no rush to chase.